Abstract
Background: Systemic and vascular inflammation is at the heart of the thrombotic occlusion of coronary arteries.
Hypothesis: The study was undertaken to determine the relationship between established inflammatory markers (inter‐leukin‐6 [IL‐6] and high‐sensitivity C‐reactive protein [hs‐CRP]), neutrophil or white cell count, and concomitant autonomic tone in patients with coronary artery disease soon after occlusive events.
Methods: We tested the linkage between autonomic tone (as defined using both time domain and frequency domain estimates of heart rate variability [HRV]) and circulating markers of inflammation (white cell counts, hs‐CRP, and IL‐6) in a sample of 100 patients with proven acute coronary syndrome and compared these with healthy controls (n = 49) and the relationships on repeated measures at 4 months in recovery (n = 51).
Results: We demonstrated predictable depressed HRV in acute patients who tended to show recovery by 4 months. The acute changes in HRV indices (e.g., triangular index) showed modest negative correlation (r = −0.2‐0.3) with the acute elevation of white cell count, IL‐6, and hs‐CRP. These associations did not persist on multivariate analysis of data gathered at 4 months post event.
Conclusion: These observational data, while limited, are the first to link autonomic tone and in particular sympathetic tone (as indicated by HRV), to the process of acute leukocytosis and systemic inflammation common in acute coronary syndromes.
Keywords: Autonomic tone, heart rate variability, markers of inflammation, acute coronary syndromes, myocardial infarction
Full Text
The Full Text of this article is available as a PDF (66.6 KB).
References
- 1. Ross R: Atherosclerosis—an inflammatory disease. N Engl J Med 1999; 340: 115–126 [DOI] [PubMed] [Google Scholar]
- 2. Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, and Braunwald E: C‐reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes : A TIMIIIA substudy. J Am Coll Cardiol 1998; 31: 1460–1465 [DOI] [PubMed] [Google Scholar]
- 3. Biasucci LM, Liuzzo G, Fantuzzi G, Caligiuri G, Rebuzzi AG, Ginnetti F, Dinarello CA, Maseri A: Increasing levels of interleukin (IL) –1Ra and IL‐6 during the first two days of hospitalization in unstable angina are associated with increased risk of in‐hospital coronary events. Circulation 1999; 99: 2079–2084 [DOI] [PubMed] [Google Scholar]
- 4. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L: Markers of myocardial damage and inflammation in relation to long‐term mortality in unstable coronary disease. FRISC study group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med 2000; 343: 1139–1147 [DOI] [PubMed] [Google Scholar]
- 5. Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, Hutchinson WL, Pepys MB: C‐Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle aged men: Results from the MONICA Augsburg Cohort Study, 1984–1992. Circulation 1999; 99: 237–242 [DOI] [PubMed] [Google Scholar]
- 6. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH: Plasma concentrations of interleukin 6 and the risk of future myocardial infarction among apparently healthy middle aged men. Circulation 2000; 101: 1767–1772 [DOI] [PubMed] [Google Scholar]
- 7. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH: Prospective study of C‐reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998; 98: 731–733 [DOI] [PubMed] [Google Scholar]
- 8. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology : Heart rate variability: Standards of measurement, physiological interpretation and clinical use. Circulation 1996; 1043–1065 [PubMed]
- 9. Tsuji H, Vendetti FJ Jr, Manders ES, Evans JC, Larson MG, Feldman CL, Levy D: Reduced heart rate variability and mortality risk in an elderly cohort: The Framingham Heart Study. Circulation 1994; 90: 878–883 [DOI] [PubMed] [Google Scholar]
- 10. Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ, and the Multicenter Post‐Infarction Research Group : Decreased heart rate variability and its association with increased mortality after myocardial infarction. Am J Cardiol 1987; 59: 256–262 [DOI] [PubMed] [Google Scholar]
- 11. Bigger JT Jr, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN: Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992; 85: 164–171 [DOI] [PubMed] [Google Scholar]
- 12. Kaplan JR, Manuck SP, Clarkson TB: The influence of heart rate on coronary atherosclerosis. J Cardiovasc Pharm 1987; 10 (suppl): S100–S102 [PubMed] [Google Scholar]
- 13. Beere PA, Glagov S, Zarins CK: Retarding effect of lowered heart rate on coronary atherosclerosis. Science 1984; 226: 180–182 [DOI] [PubMed] [Google Scholar]
- 14. Huikuri HV, Jokinen V, Syvanne M, Nieminen MS, Airaksinen KEJ, Ikaheimo MJ, Koistinen JM, Kauma H, Kesaniemi AY, Majahalme S, Niemela KO, Frick MH: Heart rate variability and progression of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1999; 19: 1979–1985 [DOI] [PubMed] [Google Scholar]
- 15. Sajadieh A, Nieslen OW, Rasmussen V, Hein HO, Abedini S, Hansen JF: Increased heart rate and reduced heart rate variability are associated with subclinical inflammation in middle‐aged and elderly subjects with no apparent heart disease. Eur Heart J 2004; 25: 363–370 [DOI] [PubMed] [Google Scholar]
- 16. Backes JM, Howard PA, Moriarty PM: Role of C reactive protein in cardiovascular disease. Ann Pharmacother 2004; 38: 110–118 [DOI] [PubMed] [Google Scholar]
- 17. Owen N, Steptoe A: Natural killer cell and proinflammatory cytokine response to mental stress: Associations with heart rate and heart rate variability. Biol Psychol 2003; 63: 101–115 [DOI] [PubMed] [Google Scholar]
- 18. Shehab AM, MacFadyen RJ, McLaren M, Tavendale R, Belch JJ, Struthers AD: Sudden unexpected death in heart failure may be preceded by short term, intraindividual increases in inflammation and in autonomic dysfunction: A pilot study. Heart 2004; 90: 1263–1268 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Liuozzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys AG, Maseri A: The prognostic value of C‐reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994; 331: 417–424 [DOI] [PubMed] [Google Scholar]
- 20. Alpert JS, Thygesen K, Antman E, Bassand JP: Myocardial infarction redefined: A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959–969 [DOI] [PubMed] [Google Scholar]
- 21. Miyao Y, Yasue H, Ogawa H, Misumi I, Masuda T, Sakamoto T, Morita E: Elevated plasma interleukin‐6 levels in patients with acute myocardial infarction. Am Heart J 1993; 126: 1299–1304 [DOI] [PubMed] [Google Scholar]
- 22. Casolo GC, Stroder P, Sigorini C, Calzolari F, Zucchini M, Balli E, Sulla A, Lazzerini S: Heart rate variability during the acute phase of myocardial infarction. Circulation 1992; 85: 2073–2079 [DOI] [PubMed] [Google Scholar]
- 23. Bigger JT Jr, Fleiss JL, Rolnitzky LM, Steinman RC, Schneider WJ: Time course of recovery of heart period variability after myocardial infarction. J Am Coll Cardiol 1991; 18: 1643–1649 [DOI] [PubMed] [Google Scholar]
- 24. Lombardi F: Clinical implications of present physiological understanding of HRV components. Cardiac Electrophysiol Rev 2002; 6: 245–249 [DOI] [PubMed] [Google Scholar]
- 25. Stein PK, Kleiger RE: Insights from the study of heart rate variability. Ann Rev Med 1999; 50: 249–261 [DOI] [PubMed] [Google Scholar]
- 26. Aronson D, Mittelman MA, Burger AJ: Interleukin‐6 levels are inversely correlated with heart rate variability in patients with decompensated heart failure. J Cardiovasc Electrophysiol 2001; 12: 294–300 [DOI] [PubMed] [Google Scholar]
- 27. Hasegawa T, Watase H: Association of heart rate with coronary risk factors and increased white blood cell counts in healthy individuals. J Atheroscler Thromb 2003; 10: 259–263 [DOI] [PubMed] [Google Scholar]
- 28. Maestroni GJ, Cosentino M, Marino F, Togni M, Conti A, Lecchini S, Frigo G: Neural and endogenous catecholamines in the bone marrow. Circadian association of norepinephrine with haematopoiesis? Exp Hematol 1998; 26: 1172–1177 [PubMed] [Google Scholar]
- 29. Maestroni JG, Conti A: Modulation of haematopoiesis via alpha 1‐adrenergic receptors on bone marrow cells. Exp Hematol 1994; 22: 313–320 [PubMed] [Google Scholar]
- 30. Kasahara K, Tanaka S, Hamashima Y: Suppressed immune response to T‐cell dependent antigen in chemically sympathectomized mice. Res Commun Chem Pathol Pharmacol 1977; 18: 533–542 [PubMed] [Google Scholar]
- 31. Juttler E, Tarabin V, Schwaniger M: Interleukin 6: A possible neuromodulator induced by neuronal activity. Neuroscientist 2002; 8: 268–275 [DOI] [PubMed] [Google Scholar]
- 32. Torpy DJ, Papanicolaou DA, Lotisikas AJ, Wilder RL, Chrousos GP, Pillemer SR: Responses of the sympathetic nervous system and the hypothalamic‐pituitary‐adrenal axis to interleukin‐6: A pilot study in fibromylagia. Arthrit and Rheumat 2000; 43; 872–880 [DOI] [PubMed] [Google Scholar]
- 33. Barath P, Fishbein MC, Cao J, Berenson J, Helfant RH, Forester JS: Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol 1990; 65: 297–302 [DOI] [PubMed] [Google Scholar]
- 34. Seino Y, Ikeda U, Ikeda M, Yamamoto K, Misawa Y, Hasegawa T, Kano S, Shimada K: Interleukin‐6 gene transcripts are expressed in human atherosclerotic lesions. Cytokine 1994; 6: 87–91 [DOI] [PubMed] [Google Scholar]
- 35. Heinrich PC, Castell JV, Andus T: Interleukin‐6 and the acute phase response. Biochem J 1990; 265: 621–636 [DOI] [PMC free article] [PubMed] [Google Scholar]